UK – UK’s MHRA starts rolling review of Moderna’s COVID-19 vaccine

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has begun the rolling review process of Moderna’s COVID-19 vaccine candidate, mRNA-1273.

This means that Moderna has started the rolling submission of mRNA-1273 for rolling review, in consideration of a potential authorisation by the MHRA.

The potential authorisation depends upon whether or not the vaccine candidate meets the MHRA’s rigorous standards of safety, effectiveness and quality standards, Moderna added in a statement.

“We appreciate the collaboration we have had to date with regulatory authorities around the world, and the process established by the MHRA to address this ongoing public health emergency,” said Stéphane Bancel, chief executive officer of Moderna…